SCHEMBL21890175

SCHEMBL21890175

c1ccc(-n2c3cc4c(cc3c3c5c(ccc32)sc2ccccc25)c2cccnc2n2c3ccccc3nc42)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.36
KDM4E B2RXH2 4/20 0.34
MAPT P10636 3/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PDE10A Q9Y233 7/20 0.33
ALDH1A1 P00352 5/20 0.33
HPGD P15428 5/20 0.33
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
FEN1 P39748 1/20 0.31
CYP2C19 P33261 2/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PDE1B Q01064 1/20 0.31
PDE3A Q14432 1/20 0.31
PDE11A Q9HCR9 1/20 0.31
TSHR P16473 1/20 0.31
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21890174 0.90 HPGD (0.34) ACHEKDM4EMAPTLMNATP53
SCHEMBL21890173 0.90 KDM4E (0.37) KDM4EMAPTLMNATP53POLB
SCHEMBL21890462 0.89 KDM4E (0.39) KDM4EMAPTLMNATP53POLB
SCHEMBL21890261 0.88 ACHE (0.35) ACHEKDM4EMAPTLMNATP53
SCHEMBL21890671 0.88 ACHE (0.35) ACHEKDM4EMAPTLMNATP53
SCHEMBL21890603 0.87 ACHE (0.38) ACHEKDM4EMAPTLMNATP53
SCHEMBL21890808 0.87 ACHE (0.38) ACHEKDM4EMAPTLMNATP53
SCHEMBL21890333 0.84 KDM4E (0.37) KDM4EMAPTLMNATP53POLB
SCHEMBL21890323 0.84 KDM4E (0.37) KDM4EMAPTLMNATP53POLB
SCHEMBL23948931 0.82 KDM4E (0.36) KDM4EMAPTLMNATP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230068759-A1 DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2023-03-02 US disclosed
US-20200227656-A1 DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2020-07-16 US disclosed
US-10615349-B2 Donor-acceptor type thermally activated delayed fluorescent materials based on imidazo[1,2-F]phenanthridine and analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2020-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200227656-A1 DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES SUN2, STAU1, HELZ ACHE 2077/4885KDM4E 4206/4885MAPT 2512/4885
US-20230068759-A1 DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES SUN2, STAU1, HELZ ACHE 2077/4885KDM4E 4206/4885MAPT 2512/4885
US-10615349-B2 Donor-acceptor type thermally activated delayed fluorescent materials based on imidazo[1,2-F]phenanthridine and analogues SUN2, STAU1, HELZ ACHE 2077/4885KDM4E 4206/4885MAPT 2512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.